Pages that link to "Item:Q2893405"
From MaRDI portal
The following pages link to Comparing Biomarkers as Principal Surrogate Endpoints (Q2893405):
Displaying 14 items.
- Assessing the value of a censored surrogate outcome (Q118842) (← links)
- Identification of causal effects within principal strata using auxiliary variables (Q2075703) (← links)
- Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials (Q2846433) (← links)
- Surrogate Measures and Consistent Surrogates (Q2861938) (← links)
- Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling (Q3119801) (← links)
- A Multiple Imputation Approach for the Evaluation of Surrogate Markers in the Principal Stratification Causal Inference Framework (Q4984852) (← links)
- A unified evaluation of differential vaccine efficacy (Q6047741) (← links)
- Evaluating multiple surrogate markers with censored data (Q6055488) (← links)
- Testing for Heterogeneity in the Utility of a Surrogate Marker (Q6079768) (← links)
- Semiparametric pseudo-score and pseudo-likelihood for evaluating correlate of protection in vaccine trials (Q6626858) (← links)
- Identification of the optimal treatment regimen in the presence of missing covariates (Q6627308) (← links)
- Quantifying the feasibility of shortening clinical trial duration using surrogate markers (Q6628174) (← links)
- Estimation of the proportion of treatment effect explained by a high-dimensional surrogate (Q6628359) (← links)
- Simultaneous inference of treatment effect modification by intermediate response endpoint principal strata with application to vaccine trials (Q6636037) (← links)
